HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nonsurgical management of live tubal ectopic pregnancy by ultrasound-guided local injection and systemic methotrexate.

AbstractSTUDY OBJECTIVE:
To evaluate outcomes relative to treatment using systemic methotrexate (MTX) alone or systemic MTX combined with ultrasound (US)-guided local injection of potassium chloride (KCl) or MTX in women with live tubal ectopic pregnancies.
DESIGN:
Case-control study (Canadian Task Force classification II-2).
SETTING:
Departments of Obstetrics and Gynecology in 2 hospitals in China.
PATIENTS:
Eighty-two women with live tubal ectopic pregnancies.
INTERVENTION:
Participants in the study received treatment using either systemic MTX (n = 37; systemic treatment group) or systemic MTX and US-guided local injection of either MTX or KCl (n = 45; combined treatment group).
MEASUREMENTS AND MAIN RESULTS:
Patient clinical features and outcomes were compared. There were no significant differences between the patient groups insofar as baseline gestational age, β-human chorionic gonadotropin concentration, or size of conceptus. The success rate in patients who received combined therapy (93.3%) was much higher than in those who received only systemic treatment (73.0%) (p < .05). In the combined treatment group, the success rate was similar between women who received locally injected KCl (95.2%) and those who received locally injected MTX (91.7%).
CONCLUSION:
The significantly higher success rate in patients who received combined US-guided local injection and systemic MTX suggests that this is an efficient nonsurgical option in women with tubal pregnancy, high serum β-human chorionic gonadotropin concentration, and fetal cardiac activity.
AuthorsMingyi Wang, Biliang Chen, Jian Wang, Xiangdong Ma, Yu Wang
JournalJournal of minimally invasive gynecology (J Minim Invasive Gynecol) 2014 Jul-Aug Vol. 21 Issue 4 Pg. 642-9 ISSN: 1553-4669 [Electronic] United States
PMID24462855 (Publication Type: Journal Article, Randomized Controlled Trial)
CopyrightCopyright © 2014 AAGL. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Abortifacient Agents, Nonsteroidal
  • Potassium Chloride
  • Methotrexate
Topics
  • Abortifacient Agents, Nonsteroidal (therapeutic use)
  • Adult
  • Case-Control Studies
  • China
  • Female
  • Gestational Age
  • Humans
  • Injections
  • Methotrexate (therapeutic use)
  • Potassium Chloride (therapeutic use)
  • Pregnancy
  • Pregnancy, Tubal (drug therapy)
  • Treatment Outcome
  • Ultrasonography, Interventional (methods)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: